PTAFR Knockout A-549 Cell Line

PTAFR Knockout A-549 Cell Line
15% OFF
Cat.No.:

EDC07964

Species:

Human

Cell Name:

A-549

Gene:

PTAFR

Gene ID:

5724

Size:

1×10⁶cells

PTAFR Knockout Cell Line (A549) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
Cat.No. EDC07964
Product Name PTAFR Knockout A549 Cell Line
Cell Line A-549
Cellosaurus ID CVCL_0023
Cell Line Synonyms A 549, A549, NCI-A549, A549/ATCC, A549 ATCC, A549ATCC, hA549
Gene PTAFR
NCBI Gene ID
Gene Synonyms PAFR
Summary
This gene encodes a seven-transmembrane G-protein-coupled receptor for platelet-activating factor (PAF) that localizes to lipid rafts and/or caveolae in the cell membrane. PAF (1-0-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine) is a phospholipid that plays a significant role in oncogenic transformation, tumor growth, angiogenesis, metastasis, and pro-inflammatory processes. Binding of PAF to the PAF-receptor (PAFR) stimulates numerous signal transduction pathways including phospholipase C, D, A2, mitogen-activated protein kinases (MAPKs), and the phosphatidylinositol-calcium second messenger system. Following PAFR activation, cells become rapidly desensitized and this refractory state is dependent on PAFR phosphorylation, internalization, and down-regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
Associated Diseases Non-Small Cell Lung Carcinoma
Morphology Adherent
Passage Ratio 1/5-1/4 ,2days
Complete Culture Medium F-12K + 10% FBS
Freezing Medium 95% Complete culture medium + 5% DMSO
QC Indels validated by Sanger sequencing; sterility confirmed via microbial testing.
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
LociSTR Info (Sample Cell)
Sample Cell Line: A-549
STR Info (Cell bank)
Cell Line: A-549
Allele1Allele2Allele1Allele2
Amelogenin X Y X Y
CSF1PO 10 12 10 12
D2S1338 24 24
D3S1358 16 16
D5S818 11 11
D7S820 8 11 8 11
D8S1179 13 14 13 14
D13S317 11 11
D16S539 11 12 11 12
D18S51 14 17 14 17
D19S433 13 13
D21S11 29 29
FGA 23 23
Penta D 9 9
Penta E 7 11 7 11
TH01 8 9.3 8 9.3
TPOX 8 11 8 11
vWA 14 14
D6S1043 11 13
D12S391 18 18
D2S441 10 13 10 13
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.

FAQ

The choice depends on whether you are studying PTAFR's role as the platelet-activating factor (PAF) receptor in lung biology or its emerging functions in lung cancer biology. The Knockout line is the standard tool for asking whether PTAFR is required for PAF-induced signaling — PAFR is a Gq/Gi-coupled GPCR mediating inflammatory and proliferative responses to PAF and structurally related oxidized phospholipids. Overexpression is useful for studying PAFR in cancer contexts. For lung biology and cancer research, the EDITGENE PTAFR Knockout in A-549 is highly relevant — A-549 is an NSCLC model, and PAFR signaling has been implicated in lung cancer progression, particularly post-chemotherapy where oxidized phospholipids from dying cells activate PAFR on surviving tumor cells. Rescue with wild-type or signaling-deficient PAFR enables structure-function studies. The knockout is a critical specificity control for PAFR antagonists (rupatadine, lexipafant) in research applications.
Primary applications: • PAF-induced signaling: intracellular calcium mobilization and ERK activation following PAF stimulation in lung cancer context. • Chemotherapy-induced tumor regrowth: studies of oxidized phospholipid-PAFR signaling in chemotherapy survivors — emerging mechanism of post-chemotherapy tumor progression. • Inflammatory response: PAF-induced inflammatory cytokine production and downstream signaling in epithelial context. • PAFR antagonist specificity: critical genetic control for rupatadine, lexipafant, and other PAFR-targeting compounds. EDITGENE recommends this model for researchers investigating platelet-activating factor receptor biology, lung cancer-associated PAF signaling, and PAFR-targeted research applications.
Yes. PAFR rescue experiments require attention to GPCR topology: • Construct design: use a codon-modified PTAFR sequence with a small intracellular C-terminal tag (FLAG, HA). PAFR is a seven-transmembrane GPCR — preserve extracellular ligand-binding regions. • Signaling-deficient rescue: DRY motif mutations enable separating ligand binding from intracellular signaling. • Functional readout: rescue should restore PAF-induced calcium mobilization (Gq-coupled signaling) and ERK activation. A-549 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.

Recommended Accessories

Related Products

Flash CRISPR Knockout Kit(Universal Version)Flash CRISPR Knockout Kit(Universal Version)
Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)

Related Services

Knockout Cell LineKnockout Cell Line
Contact Us
*
*
*
*
How did you hear about us: